QUCY

Mainz Biomed N.V. NASDAQ

Healthcare ·Medical - Diagnostics & Research ·DE · mainzbiomed.com

$0.39

Mkt Cap $4.9M

52w Low $0.38 3.1% of range 52w High $0.79

50d MA $0.74 200d MA $0.74

P/E (TTM) -0.0x

EV/EBITDA 0.1x

P/B 0.1x

Debt/Equity 0.5x

ROE -2526.6%

P/FCF -0.0x

RSI (14) —

ATR (14) —

Beta 0.47

50d MA $0.74

200d MA $0.74

Avg Volume 909.8K

About

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.

Recent Filings

8-K · 1.01 ! Medium

Unknown — 8-K 1.01: Equity Issuance

QUCY issued $2.5M in preferred shares, diluting common equity and raising cash for operations, which signals either financial stress or growth investment depending on how proceeds are deployed.

Apr 15

8-K

Unknown — 8-K Filing

QUCY faces delisting risk from Nasdaq due to low stock price but has 180 days to cure through a potential reverse split, which would dilute existing shareholders while attempting to restore compliance.

Mar 25

8-K · 8.01 !! High

Unknown — 8-K 8.01: Material Event / Announcement

Quantum Computing Inc. is completing a private placement to raise capital, with proceeds designated for specific corporate purposes pending stockholder approval and closing conditions—investors should monitor approval timelines and dilution impact.